To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Solarase Approved In Canada For Precancerous Skin Lesions URL: http://www.pslgroup.com/dg/7D9AE.htm Doctor's Guide May 20, 1998
MISSISSAUGA, ON -- May 20, 1998 -- The Therapeutic Products Directorate of Health Canada (formerly HPB) has granted marketing approval to Hyal Pharmaceutical Corp.'s Solarase™, a topical gel formulation to treat actinic keratosis (AK), precancerous skin lesions caused by exposure to the sun. AK is a common precancerous skin lesion caused by overexposure to sunlight. A small number of these lesions will develop into squamus cell carcinoma, a malignant skin disease. According to The Skin Cancer Foundation of the United States, AK affects one in six people world-wide. Hyal expects to file a submission to the FDA in the third quarter seeking approval to market Solarase in the U.S. Solarase utilises Hyal's patented HIT technology which targets and retains drugs in areas of dermal pathology. The benefits to the patient are minimal systemic drug absorption and outstanding safety. More information on: Solarase and Hyal Pharmaceutical Corp. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.